Related Experiment Video
Updated: Feb 26, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Novel systemic therapy against malignant pleural mesothelioma
Michael R Mancuso1, Joel W Neal1
1Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Translational Lung Cancer Research
|July 18, 2017
Summary
Malignant pleural mesothelioma (MPM) treatment faces challenges. This review explores novel systemic therapies beyond standard chemotherapy, including immunotherapy, to improve outcomes for this aggressive cancer.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor prognosis.
- Current first-line treatments offer limited long-term survival, and no standard therapy exists for relapsed or refractory disease.
Purpose of the Study:
- To review and analyze emerging systemic therapies for malignant pleural mesothelioma.
- To highlight challenges and future directions in developing effective treatments for MPM.
Main Methods:
- Review of current literature on systemic therapy for MPM.
- Analysis of novel therapeutic strategies including targeted therapies, epigenome modulation, and immunotherapy.
Main Results:
- Standard treatments show limited efficacy for advanced or recurrent MPM.
- Investigational therapies show promise, including targeting mesothelin, epigenetic modifiers, and immune checkpoints.
Conclusions:
- Developing improved systemic therapies for MPM remains a significant challenge.
- Novel strategies like immunotherapy and targeted agents are crucial for future treatment paradigms in MPM.
More Related Videos
Related Concept Videos
01:30Pleural Disorders: Types and Brief Description
795
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
795
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K